nodes	percent_of_prediction	percent_of_DWPC	metapath
Fexofenadine—ABCB1—melanoma	0.414	1	CbGaD
Fexofenadine—SLCO1B3—Docetaxel—melanoma	0.214	0.513	CbGbCtD
Fexofenadine—CYP2D6—Vemurafenib—melanoma	0.0983	0.235	CbGbCtD
Fexofenadine—ABCB1—Dactinomycin—melanoma	0.0693	0.166	CbGbCtD
Fexofenadine—ABCB1—Docetaxel—melanoma	0.0358	0.0856	CbGbCtD
Fexofenadine—Paranoia—Carmustine—melanoma	0.00281	0.0235	CcSEcCtD
Fexofenadine—Atrial fibrillation—Vemurafenib—melanoma	0.00277	0.0232	CcSEcCtD
Fexofenadine—Pain in extremity—Vemurafenib—melanoma	0.00263	0.022	CcSEcCtD
Fexofenadine—Chest tightness—Docetaxel—melanoma	0.00262	0.0219	CcSEcCtD
Fexofenadine—Otitis media—Temozolomide—melanoma	0.00238	0.0199	CcSEcCtD
Fexofenadine—Accidental injury—Carmustine—melanoma	0.00216	0.0181	CcSEcCtD
Fexofenadine—Viral infection—Temozolomide—melanoma	0.00205	0.0171	CcSEcCtD
Fexofenadine—Injury—Bleomycin—melanoma	0.00173	0.0145	CcSEcCtD
Fexofenadine—Dry eye—Temozolomide—melanoma	0.00171	0.0143	CcSEcCtD
Fexofenadine—Otitis media—Docetaxel—melanoma	0.00158	0.0132	CcSEcCtD
Fexofenadine—Ear pain—Temozolomide—melanoma	0.00157	0.0132	CcSEcCtD
Fexofenadine—Back pain—Vemurafenib—melanoma	0.00153	0.0128	CcSEcCtD
Fexofenadine—Rhinorrhoea—Docetaxel—melanoma	0.00152	0.0127	CcSEcCtD
Fexofenadine—Injury—Carmustine—melanoma	0.00151	0.0126	CcSEcCtD
Fexofenadine—Thirst—Temozolomide—melanoma	0.00141	0.0118	CcSEcCtD
Fexofenadine—Chest discomfort—Docetaxel—melanoma	0.00139	0.0116	CcSEcCtD
Fexofenadine—Cough—Vemurafenib—melanoma	0.00138	0.0115	CcSEcCtD
Fexofenadine—Myalgia—Vemurafenib—melanoma	0.00135	0.0113	CcSEcCtD
Fexofenadine—Anaphylactic shock—Vemurafenib—melanoma	0.00129	0.0108	CcSEcCtD
Fexofenadine—Infection—Vemurafenib—melanoma	0.00128	0.0107	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00118	0.00983	CcSEcCtD
Fexofenadine—Fatigue—Vemurafenib—melanoma	0.00111	0.0093	CcSEcCtD
Fexofenadine—Upper respiratory tract infection—Temozolomide—melanoma	0.00108	0.00901	CcSEcCtD
Fexofenadine—Pollakiuria—Temozolomide—melanoma	0.00107	0.00896	CcSEcCtD
Fexofenadine—Flushing—Bleomycin—melanoma	0.00102	0.00854	CcSEcCtD
Fexofenadine—Body temperature increased—Vemurafenib—melanoma	0.00102	0.00853	CcSEcCtD
Fexofenadine—Cardiac failure congestive—Docetaxel—melanoma	0.000985	0.00823	CcSEcCtD
Fexofenadine—Sinusitis—Temozolomide—melanoma	0.000971	0.00811	CcSEcCtD
Fexofenadine—Flushing—Dactinomycin—melanoma	0.000954	0.00797	CcSEcCtD
Fexofenadine—Hypersensitivity—Vemurafenib—melanoma	0.000952	0.00795	CcSEcCtD
Fexofenadine—Atrial fibrillation—Docetaxel—melanoma	0.000943	0.00787	CcSEcCtD
Fexofenadine—Asthenia—Vemurafenib—melanoma	0.000927	0.00774	CcSEcCtD
Fexofenadine—Pruritus—Vemurafenib—melanoma	0.000914	0.00763	CcSEcCtD
Fexofenadine—Pain in extremity—Docetaxel—melanoma	0.000893	0.00746	CcSEcCtD
Fexofenadine—Flushing—Carmustine—melanoma	0.000893	0.00745	CcSEcCtD
Fexofenadine—Diarrhoea—Vemurafenib—melanoma	0.000884	0.00738	CcSEcCtD
Fexofenadine—Flushing—Temozolomide—melanoma	0.000863	0.0072	CcSEcCtD
Fexofenadine—Dizziness—Vemurafenib—melanoma	0.000854	0.00714	CcSEcCtD
Fexofenadine—Cough—Bleomycin—melanoma	0.000837	0.00699	CcSEcCtD
Fexofenadine—Vomiting—Vemurafenib—melanoma	0.000822	0.00686	CcSEcCtD
Fexofenadine—Myalgia—Bleomycin—melanoma	0.000817	0.00682	CcSEcCtD
Fexofenadine—Rash—Vemurafenib—melanoma	0.000815	0.0068	CcSEcCtD
Fexofenadine—Dermatitis—Vemurafenib—melanoma	0.000814	0.0068	CcSEcCtD
Fexofenadine—Back pain—Carmustine—melanoma	0.00081	0.00676	CcSEcCtD
Fexofenadine—Headache—Vemurafenib—melanoma	0.000809	0.00676	CcSEcCtD
Fexofenadine—Nasopharyngitis—Docetaxel—melanoma	0.000799	0.00667	CcSEcCtD
Fexofenadine—Vision blurred—Carmustine—melanoma	0.000789	0.00659	CcSEcCtD
Fexofenadine—Anaphylactic shock—Bleomycin—melanoma	0.000783	0.00654	CcSEcCtD
Fexofenadine—Back pain—Temozolomide—melanoma	0.000783	0.00654	CcSEcCtD
Fexofenadine—Infection—Bleomycin—melanoma	0.000778	0.0065	CcSEcCtD
Fexofenadine—Agitation—Carmustine—melanoma	0.000769	0.00643	CcSEcCtD
Fexofenadine—Nausea—Vemurafenib—melanoma	0.000767	0.00641	CcSEcCtD
Fexofenadine—Vision blurred—Temozolomide—melanoma	0.000763	0.00637	CcSEcCtD
Fexofenadine—Myalgia—Dactinomycin—melanoma	0.000762	0.00636	CcSEcCtD
Fexofenadine—Agitation—Temozolomide—melanoma	0.000744	0.00621	CcSEcCtD
Fexofenadine—Angioedema—Temozolomide—melanoma	0.000739	0.00617	CcSEcCtD
Fexofenadine—Infection—Dactinomycin—melanoma	0.000725	0.00606	CcSEcCtD
Fexofenadine—Palpitations—Temozolomide—melanoma	0.000715	0.00597	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Bleomycin—melanoma	0.000713	0.00596	CcSEcCtD
Fexofenadine—Myalgia—Carmustine—melanoma	0.000713	0.00595	CcSEcCtD
Fexofenadine—Cough—Temozolomide—melanoma	0.000706	0.0059	CcSEcCtD
Fexofenadine—Dyspnoea—Bleomycin—melanoma	0.000698	0.00583	CcSEcCtD
Fexofenadine—Myalgia—Temozolomide—melanoma	0.000689	0.00575	CcSEcCtD
Fexofenadine—Infection—Carmustine—melanoma	0.000679	0.00567	CcSEcCtD
Fexofenadine—Dry mouth—Temozolomide—melanoma	0.000674	0.00563	CcSEcCtD
Fexofenadine—Pain—Bleomycin—melanoma	0.000669	0.00559	CcSEcCtD
Fexofenadine—Tachycardia—Carmustine—melanoma	0.000667	0.00557	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000665	0.00556	CcSEcCtD
Fexofenadine—Anaphylactic shock—Temozolomide—melanoma	0.00066	0.00551	CcSEcCtD
Fexofenadine—Infection—Temozolomide—melanoma	0.000656	0.00548	CcSEcCtD
Fexofenadine—Epistaxis—Docetaxel—melanoma	0.000649	0.00542	CcSEcCtD
Fexofenadine—Fatigue—Dactinomycin—melanoma	0.000629	0.00526	CcSEcCtD
Fexofenadine—Pain—Dactinomycin—melanoma	0.000624	0.00521	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Carmustine—melanoma	0.000623	0.0052	CcSEcCtD
Fexofenadine—Urticaria—Bleomycin—melanoma	0.000622	0.00519	CcSEcCtD
Fexofenadine—Body temperature increased—Bleomycin—melanoma	0.000619	0.00517	CcSEcCtD
Fexofenadine—Insomnia—Carmustine—melanoma	0.000618	0.00516	CcSEcCtD
Fexofenadine—Dyspnoea—Carmustine—melanoma	0.000609	0.00509	CcSEcCtD
Fexofenadine—Somnolence—Carmustine—melanoma	0.000607	0.00507	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Temozolomide—melanoma	0.000602	0.00502	CcSEcCtD
Fexofenadine—Insomnia—Temozolomide—melanoma	0.000597	0.00499	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Dactinomycin—melanoma	0.000597	0.00499	CcSEcCtD
Fexofenadine—Dyspnoea—Temozolomide—melanoma	0.000589	0.00492	CcSEcCtD
Fexofenadine—Somnolence—Temozolomide—melanoma	0.000587	0.0049	CcSEcCtD
Fexofenadine—Pain—Carmustine—melanoma	0.000584	0.00488	CcSEcCtD
Fexofenadine—Dyspepsia—Temozolomide—melanoma	0.000581	0.00485	CcSEcCtD
Fexofenadine—Abdominal pain—Dactinomycin—melanoma	0.000577	0.00482	CcSEcCtD
Fexofenadine—Body temperature increased—Dactinomycin—melanoma	0.000577	0.00482	CcSEcCtD
Fexofenadine—Hypersensitivity—Bleomycin—melanoma	0.000577	0.00482	CcSEcCtD
Fexofenadine—Flushing—Docetaxel—melanoma	0.000574	0.00479	CcSEcCtD
Fexofenadine—Fatigue—Temozolomide—melanoma	0.000569	0.00475	CcSEcCtD
Fexofenadine—Pain—Temozolomide—melanoma	0.000565	0.00472	CcSEcCtD
Fexofenadine—Asthenia—Bleomycin—melanoma	0.000562	0.00469	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Carmustine—melanoma	0.000559	0.00467	CcSEcCtD
Fexofenadine—Pruritus—Bleomycin—melanoma	0.000554	0.00463	CcSEcCtD
Fexofenadine—Body temperature increased—Carmustine—melanoma	0.00054	0.00451	CcSEcCtD
Fexofenadine—Abdominal pain—Carmustine—melanoma	0.00054	0.00451	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Temozolomide—melanoma	0.00054	0.00451	CcSEcCtD
Fexofenadine—Hypersensitivity—Dactinomycin—melanoma	0.000538	0.00449	CcSEcCtD
Fexofenadine—Urticaria—Temozolomide—melanoma	0.000525	0.00438	CcSEcCtD
Fexofenadine—Asthenia—Dactinomycin—melanoma	0.000524	0.00437	CcSEcCtD
Fexofenadine—Body temperature increased—Temozolomide—melanoma	0.000522	0.00436	CcSEcCtD
Fexofenadine—Abdominal pain—Temozolomide—melanoma	0.000522	0.00436	CcSEcCtD
Fexofenadine—Back pain—Docetaxel—melanoma	0.00052	0.00435	CcSEcCtD
Fexofenadine—Hypersensitivity—Carmustine—melanoma	0.000503	0.0042	CcSEcCtD
Fexofenadine—Diarrhoea—Dactinomycin—melanoma	0.0005	0.00417	CcSEcCtD
Fexofenadine—Vomiting—Bleomycin—melanoma	0.000498	0.00416	CcSEcCtD
Fexofenadine—Rash—Bleomycin—melanoma	0.000494	0.00412	CcSEcCtD
Fexofenadine—Dermatitis—Bleomycin—melanoma	0.000493	0.00412	CcSEcCtD
Fexofenadine—Asthenia—Carmustine—melanoma	0.00049	0.00409	CcSEcCtD
Fexofenadine—Hypersensitivity—Temozolomide—melanoma	0.000486	0.00406	CcSEcCtD
Fexofenadine—Palpitations—Docetaxel—melanoma	0.000475	0.00397	CcSEcCtD
Fexofenadine—Asthenia—Temozolomide—melanoma	0.000474	0.00396	CcSEcCtD
Fexofenadine—Cough—Docetaxel—melanoma	0.00047	0.00392	CcSEcCtD
Fexofenadine—Diarrhoea—Carmustine—melanoma	0.000468	0.0039	CcSEcCtD
Fexofenadine—Pruritus—Temozolomide—melanoma	0.000467	0.0039	CcSEcCtD
Fexofenadine—Nausea—Bleomycin—melanoma	0.000465	0.00388	CcSEcCtD
Fexofenadine—Vomiting—Dactinomycin—melanoma	0.000464	0.00388	CcSEcCtD
Fexofenadine—Rash—Dactinomycin—melanoma	0.00046	0.00384	CcSEcCtD
Fexofenadine—Myalgia—Docetaxel—melanoma	0.000458	0.00383	CcSEcCtD
Fexofenadine—Dizziness—Carmustine—melanoma	0.000452	0.00377	CcSEcCtD
Fexofenadine—Diarrhoea—Temozolomide—melanoma	0.000452	0.00377	CcSEcCtD
Fexofenadine—Dry mouth—Docetaxel—melanoma	0.000448	0.00374	CcSEcCtD
Fexofenadine—Anaphylactic shock—Docetaxel—melanoma	0.000439	0.00367	CcSEcCtD
Fexofenadine—Dizziness—Temozolomide—melanoma	0.000437	0.00365	CcSEcCtD
Fexofenadine—Infection—Docetaxel—melanoma	0.000436	0.00364	CcSEcCtD
Fexofenadine—Vomiting—Carmustine—melanoma	0.000434	0.00363	CcSEcCtD
Fexofenadine—Nausea—Dactinomycin—melanoma	0.000434	0.00362	CcSEcCtD
Fexofenadine—Rash—Carmustine—melanoma	0.000431	0.0036	CcSEcCtD
Fexofenadine—Dermatitis—Carmustine—melanoma	0.00043	0.00359	CcSEcCtD
Fexofenadine—Tachycardia—Docetaxel—melanoma	0.000429	0.00358	CcSEcCtD
Fexofenadine—Headache—Carmustine—melanoma	0.000428	0.00358	CcSEcCtD
Fexofenadine—Vomiting—Temozolomide—melanoma	0.00042	0.00351	CcSEcCtD
Fexofenadine—Rash—Temozolomide—melanoma	0.000416	0.00348	CcSEcCtD
Fexofenadine—Dermatitis—Temozolomide—melanoma	0.000416	0.00347	CcSEcCtD
Fexofenadine—Headache—Temozolomide—melanoma	0.000414	0.00345	CcSEcCtD
Fexofenadine—Nausea—Carmustine—melanoma	0.000406	0.00339	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Docetaxel—melanoma	0.0004	0.00334	CcSEcCtD
Fexofenadine—Insomnia—Docetaxel—melanoma	0.000397	0.00332	CcSEcCtD
Fexofenadine—Nausea—Temozolomide—melanoma	0.000392	0.00328	CcSEcCtD
Fexofenadine—Dyspnoea—Docetaxel—melanoma	0.000391	0.00327	CcSEcCtD
Fexofenadine—Somnolence—Docetaxel—melanoma	0.00039	0.00326	CcSEcCtD
Fexofenadine—Dyspepsia—Docetaxel—melanoma	0.000387	0.00323	CcSEcCtD
Fexofenadine—Fatigue—Docetaxel—melanoma	0.000379	0.00316	CcSEcCtD
Fexofenadine—Pain—Docetaxel—melanoma	0.000376	0.00314	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Docetaxel—melanoma	0.000359	0.003	CcSEcCtD
Fexofenadine—Abdominal pain—Docetaxel—melanoma	0.000347	0.0029	CcSEcCtD
Fexofenadine—Body temperature increased—Docetaxel—melanoma	0.000347	0.0029	CcSEcCtD
Fexofenadine—Hypersensitivity—Docetaxel—melanoma	0.000324	0.0027	CcSEcCtD
Fexofenadine—Asthenia—Docetaxel—melanoma	0.000315	0.00263	CcSEcCtD
Fexofenadine—Pruritus—Docetaxel—melanoma	0.000311	0.00259	CcSEcCtD
Fexofenadine—Diarrhoea—Docetaxel—melanoma	0.0003	0.00251	CcSEcCtD
Fexofenadine—Lomitapide—ABCB1—melanoma	0.000298	0.515	CrCbGaD
Fexofenadine—Dizziness—Docetaxel—melanoma	0.00029	0.00243	CcSEcCtD
Fexofenadine—Vomiting—Docetaxel—melanoma	0.000279	0.00233	CcSEcCtD
Fexofenadine—Rash—Docetaxel—melanoma	0.000277	0.00231	CcSEcCtD
Fexofenadine—Dermatitis—Docetaxel—melanoma	0.000277	0.00231	CcSEcCtD
Fexofenadine—Headache—Docetaxel—melanoma	0.000275	0.0023	CcSEcCtD
Fexofenadine—Nausea—Docetaxel—melanoma	0.000261	0.00218	CcSEcCtD
Fexofenadine—Pimozide—ABCB1—melanoma	8.5e-05	0.147	CrCbGaD
Fexofenadine—Fentanyl—ABCB1—melanoma	7.37e-05	0.127	CrCbGaD
Fexofenadine—Loperamide—ABCB1—melanoma	7.1e-05	0.123	CrCbGaD
Fexofenadine—Methadone—ABCB1—melanoma	5.05e-05	0.0874	CrCbGaD
Fexofenadine—HRH1—Signaling by GPCR—GNAQ—melanoma	2.36e-05	0.00049	CbGpPWpGaD
Fexofenadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—melanoma	2.36e-05	0.00049	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.36e-05	0.00049	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—CYP1B1—melanoma	2.36e-05	0.000489	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—melanoma	2.33e-05	0.000484	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CCR7—melanoma	2.33e-05	0.000483	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—GRM1—melanoma	2.33e-05	0.000483	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—SLC5A5—melanoma	2.33e-05	0.000483	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—MTAP—melanoma	2.32e-05	0.000481	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	2.32e-05	0.000481	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PRKCA—melanoma	2.27e-05	0.000472	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—SUFU—melanoma	2.27e-05	0.000471	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	2.27e-05	0.000471	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—GNA11—melanoma	2.26e-05	0.000469	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—ERCC2—melanoma	2.26e-05	0.000468	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PIP4K2A—melanoma	2.25e-05	0.000466	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—SLC6A11—melanoma	2.25e-05	0.000466	CbGpPWpGaD
Fexofenadine—SLCO1B1—Transmembrane transport of small molecules—ALB—melanoma	2.22e-05	0.00046	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—FASN—melanoma	2.21e-05	0.000459	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	2.21e-05	0.000458	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	2.19e-05	0.000454	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—MTAP—melanoma	2.18e-05	0.000453	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—AKT3—melanoma	2.18e-05	0.000452	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—SLC5A5—melanoma	2.18e-05	0.000452	CbGpPWpGaD
Fexofenadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—melanoma	2.17e-05	0.00045	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	2.14e-05	0.000443	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	2.13e-05	0.000442	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	2.12e-05	0.00044	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—RHOB—melanoma	2.12e-05	0.00044	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—BCL2L11—melanoma	2.12e-05	0.00044	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—GNAQ—melanoma	2.1e-05	0.000436	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—CD44—melanoma	2.1e-05	0.000436	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.08e-05	0.000432	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PHGDH—melanoma	2.07e-05	0.000429	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—LUM—melanoma	2.07e-05	0.000429	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.06e-05	0.000427	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.04e-05	0.000423	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—HDAC6—melanoma	2.04e-05	0.000423	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—HPSE—melanoma	2.03e-05	0.00042	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—EDN1—melanoma	2.02e-05	0.000419	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—CYP1B1—melanoma	2.02e-05	0.000418	CbGpPWpGaD
Fexofenadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—melanoma	2.01e-05	0.000417	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CUBN—melanoma	1.99e-05	0.000413	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—CSF2—melanoma	1.97e-05	0.000409	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—LUM—melanoma	1.95e-05	0.000404	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PHGDH—melanoma	1.95e-05	0.000404	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—ABCB1—melanoma	1.94e-05	0.000403	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CXCR2—melanoma	1.93e-05	0.000401	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—CXCL8—melanoma	1.93e-05	0.0004	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	1.93e-05	0.0004	CbGpPWpGaD
Fexofenadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—melanoma	1.92e-05	0.000399	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CSPG4—melanoma	1.92e-05	0.000399	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—BSG—melanoma	1.92e-05	0.000399	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—SDHD—melanoma	1.92e-05	0.000399	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—HPSE—melanoma	1.91e-05	0.000396	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—RAC2—melanoma	1.9e-05	0.000394	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—PRKCA—melanoma	1.89e-05	0.000392	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CUBN—melanoma	1.87e-05	0.000389	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—VEGFC—melanoma	1.87e-05	0.000388	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—WNT5A—melanoma	1.87e-05	0.000388	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.87e-05	0.000388	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GPAM—melanoma	1.86e-05	0.000386	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—EDN1—melanoma	1.83e-05	0.00038	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	1.82e-05	0.000378	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—SDHD—melanoma	1.81e-05	0.000376	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CSPG4—melanoma	1.81e-05	0.000376	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—BSG—melanoma	1.81e-05	0.000376	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—CSF2—melanoma	1.79e-05	0.000372	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PRKCA—melanoma	1.79e-05	0.000371	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PIK3CG—melanoma	1.78e-05	0.000369	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.78e-05	0.000369	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	1.77e-05	0.000368	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—ERCC2—melanoma	1.77e-05	0.000368	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GPAM—melanoma	1.75e-05	0.000364	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—RAC1—melanoma	1.75e-05	0.000364	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	1.73e-05	0.00036	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	1.73e-05	0.00036	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PPARG—melanoma	1.72e-05	0.000357	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PRKCA—melanoma	1.72e-05	0.000356	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—MAP2K2—melanoma	1.68e-05	0.000348	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—ABCB1—melanoma	1.66e-05	0.000344	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	1.65e-05	0.000343	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—F2R—melanoma	1.64e-05	0.000341	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	1.64e-05	0.00034	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—RAC1—melanoma	1.59e-05	0.00033	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—EDNRB—melanoma	1.59e-05	0.00033	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PLA2G6—melanoma	1.58e-05	0.000328	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PIK3CD—melanoma	1.57e-05	0.000325	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—ALB—melanoma	1.55e-05	0.000321	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PTK2B—melanoma	1.54e-05	0.00032	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PRKCA—melanoma	1.53e-05	0.000317	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—ERCC2—melanoma	1.52e-05	0.000314	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	1.5e-05	0.000312	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—GNA11—melanoma	1.5e-05	0.000312	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—GAB2—melanoma	1.5e-05	0.000312	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—FLT1—melanoma	1.5e-05	0.00031	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PLA2G6—melanoma	1.49e-05	0.000309	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—PIK3CG—melanoma	1.48e-05	0.000307	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.47e-05	0.000304	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	1.46e-05	0.000302	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—VCAN—melanoma	1.42e-05	0.000295	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—FOXO4—melanoma	1.41e-05	0.000293	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CXCR4—melanoma	1.41e-05	0.000293	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—HDAC2—melanoma	1.41e-05	0.000293	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PIK3CG—melanoma	1.4e-05	0.00029	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—GNAQ—melanoma	1.4e-05	0.00029	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PIK3CB—melanoma	1.36e-05	0.000283	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PTGS2—melanoma	1.35e-05	0.000281	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PPARG—melanoma	1.35e-05	0.00028	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PIK3CG—melanoma	1.35e-05	0.000279	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—VCAN—melanoma	1.34e-05	0.000278	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—SYK—melanoma	1.31e-05	0.000272	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—PIK3CD—melanoma	1.3e-05	0.00027	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—ITGAV—melanoma	1.29e-05	0.000267	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—NGFR—melanoma	1.29e-05	0.000267	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—AKT3—melanoma	1.29e-05	0.000267	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.26e-05	0.00026	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PIK3CD—melanoma	1.23e-05	0.000255	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	1.23e-05	0.000255	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—ALB—melanoma	1.21e-05	0.000252	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CYP17A1—melanoma	1.2e-05	0.000249	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PIK3CG—melanoma	1.2e-05	0.000248	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—SOCS1—melanoma	1.19e-05	0.000247	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—MAP2K1—melanoma	1.19e-05	0.000247	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—S100B—melanoma	1.19e-05	0.000247	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PIK3CD—melanoma	1.18e-05	0.000245	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PTEN—melanoma	1.18e-05	0.000245	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PPARG—melanoma	1.16e-05	0.00024	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—ERBB4—melanoma	1.14e-05	0.000236	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—PIK3CB—melanoma	1.13e-05	0.000235	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GNA11—melanoma	1.13e-05	0.000235	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CYP17A1—melanoma	1.13e-05	0.000234	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CDKN2B—melanoma	1.13e-05	0.000234	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	1.11e-05	0.00023	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—FASN—melanoma	1.11e-05	0.00023	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CD86—melanoma	1.09e-05	0.000226	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—CXCL8—melanoma	1.09e-05	0.000226	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—SLC5A5—melanoma	1.09e-05	0.000226	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—EDN1—melanoma	1.08e-05	0.000225	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PIK3CB—melanoma	1.07e-05	0.000222	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GNA11—melanoma	1.07e-05	0.000221	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PTGS2—melanoma	1.06e-05	0.00022	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CSF2—melanoma	1.06e-05	0.000219	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—FGF1—melanoma	1.06e-05	0.000219	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CD44—melanoma	1.05e-05	0.000218	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GNAQ—melanoma	1.05e-05	0.000218	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PIK3CD—melanoma	1.05e-05	0.000218	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—FASN—melanoma	1.04e-05	0.000217	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—IL2—melanoma	1.04e-05	0.000216	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—ALB—melanoma	1.04e-05	0.000215	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—E2F1—melanoma	1.04e-05	0.000215	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PIK3CB—melanoma	1.03e-05	0.000214	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—SLC5A5—melanoma	1.03e-05	0.000213	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PDGFRA—melanoma	1.02e-05	0.000213	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PRKCA—melanoma	1.01e-05	0.00021	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—ITGB3—melanoma	1.01e-05	0.00021	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CYP1B1—melanoma	1.01e-05	0.000209	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—SPP1—melanoma	9.95e-06	0.000206	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GNAQ—melanoma	9.92e-06	0.000206	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CD44—melanoma	9.92e-06	0.000206	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MAP2K2—melanoma	9.92e-06	0.000206	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—CXCL8—melanoma	9.9e-06	0.000205	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CYP1B1—melanoma	9.51e-06	0.000197	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—IL2—melanoma	9.47e-06	0.000196	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—TERT—melanoma	9.43e-06	0.000196	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—RAC1—melanoma	9.4e-06	0.000195	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PTEN—melanoma	9.27e-06	0.000192	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PIK3CB—melanoma	9.17e-06	0.00019	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PTGS2—melanoma	9.09e-06	0.000188	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—HIF1A—melanoma	9.02e-06	0.000187	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—KDR—melanoma	8.63e-06	0.000179	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PIK3CA—melanoma	8.32e-06	0.000173	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—FN1—melanoma	8.3e-06	0.000172	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—NOTCH1—melanoma	8.13e-06	0.000169	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CD80—melanoma	7.96e-06	0.000165	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—APC—melanoma	7.95e-06	0.000165	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PIK3CG—melanoma	7.95e-06	0.000165	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—KIT—melanoma	7.95e-06	0.000165	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—NRAS—melanoma	7.95e-06	0.000165	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PTEN—melanoma	7.92e-06	0.000164	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—EGF—melanoma	7.85e-06	0.000163	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ABCB1—melanoma	7.83e-06	0.000162	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PRKCA—melanoma	7.65e-06	0.000159	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—MAPK3—melanoma	7.61e-06	0.000158	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ERCC2—melanoma	7.59e-06	0.000157	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—BRAF—melanoma	7.47e-06	0.000155	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IGF1—melanoma	7.28e-06	0.000151	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—MAPK1—melanoma	7.24e-06	0.00015	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—EGFR—melanoma	7.24e-06	0.00015	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PRKCA—melanoma	7.21e-06	0.00015	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ERCC2—melanoma	7.15e-06	0.000148	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MAP2K1—melanoma	7.03e-06	0.000146	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PIK3CD—melanoma	6.99e-06	0.000145	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—PIK3CA—melanoma	6.92e-06	0.000144	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—KRAS—melanoma	6.84e-06	0.000142	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—AKT1—melanoma	6.8e-06	0.000141	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—FGF2—melanoma	6.69e-06	0.000139	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PIK3CA—melanoma	6.54e-06	0.000136	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PIK3CA—melanoma	6.28e-06	0.00013	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MDM2—melanoma	6.26e-06	0.00013	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—ERBB2—melanoma	6.17e-06	0.000128	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PIK3CB—melanoma	6.09e-06	0.000126	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PIK3CG—melanoma	5.99e-06	0.000124	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CXCL8—melanoma	5.85e-06	0.000121	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—HRAS—melanoma	5.81e-06	0.000121	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PPARG—melanoma	5.78e-06	0.00012	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CDKN1B—melanoma	5.71e-06	0.000119	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—AKT1—melanoma	5.65e-06	0.000117	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PIK3CG—melanoma	5.65e-06	0.000117	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CASP3—melanoma	5.6e-06	0.000116	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IL2—melanoma	5.59e-06	0.000116	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PIK3CA—melanoma	5.59e-06	0.000116	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—IL6—melanoma	5.56e-06	0.000115	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CCND1—melanoma	5.45e-06	0.000113	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PPARG—melanoma	5.45e-06	0.000113	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CTNNB1—melanoma	5.4e-06	0.000112	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—AKT1—melanoma	5.34e-06	0.000111	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MMP9—melanoma	5.29e-06	0.00011	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CDKN1A—melanoma	5.27e-06	0.000109	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PIK3CD—melanoma	5.27e-06	0.000109	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PTEN—melanoma	5.26e-06	0.000109	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—NFKB1—melanoma	5.24e-06	0.000109	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ALB—melanoma	5.2e-06	0.000108	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—AKT1—melanoma	5.13e-06	0.000106	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PIK3CD—melanoma	4.96e-06	0.000103	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ALB—melanoma	4.9e-06	0.000102	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—VEGFA—melanoma	4.75e-06	9.86e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—STAT3—melanoma	4.71e-06	9.76e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—NRAS—melanoma	4.69e-06	9.74e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PIK3CB—melanoma	4.59e-06	9.52e-05	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—AKT1—melanoma	4.57e-06	9.47e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PTGS2—melanoma	4.55e-06	9.44e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MAPK3—melanoma	4.5e-06	9.32e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MYC—melanoma	4.37e-06	9.07e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PIK3CB—melanoma	4.33e-06	8.97e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PTGS2—melanoma	4.29e-06	8.89e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MAPK1—melanoma	4.28e-06	8.87e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—EGFR—melanoma	4.28e-06	8.87e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—KRAS—melanoma	4.04e-06	8.38e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PTEN—melanoma	3.97e-06	8.23e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PTEN—melanoma	3.74e-06	7.75e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PIK3CA—melanoma	3.71e-06	7.7e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—TP53—melanoma	3.59e-06	7.45e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—HRAS—melanoma	3.43e-06	7.12e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IL6—melanoma	3.29e-06	6.82e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—AKT1—melanoma	3.03e-06	6.29e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PIK3CA—melanoma	2.8e-06	5.8e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PIK3CA—melanoma	2.64e-06	5.47e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—AKT1—melanoma	2.29e-06	4.74e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—AKT1—melanoma	2.15e-06	4.47e-05	CbGpPWpGaD
